Abstract P5-09-21: Selective Androgen Receptor Modulators (SARMs): Enobosarm as Targeted Therapy for the Treatment of Androgen Receptor-Positive Breast Cancer

    December 2013 in “ Cancer research
    J. T. Dalton, Ramesh Narayanan, ) Steiner
    TLDR Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.
    The study investigated the use of selective androgen receptor modulators (SARMs), specifically enobosarm, as a targeted therapy for androgen receptor-positive breast cancer. In vitro and in vivo experiments demonstrated that SARMs, including enobosarm and GTx-027, significantly inhibited the proliferation and tumor growth of AR-expressing breast cancer cells without the virilizing side effects associated with non-tissue-selective androgens. Phase II clinical studies in postmenopausal women showed that enobosarm was well tolerated and led to significant improvements in lean body mass and physical function without affecting sebaceous gland volume, hair growth, endometrial thickness, or causing bleeding. These findings suggested that SARMs could offer a novel and effective treatment option for AR-positive breast cancer.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 216 results

      community The most nuclear stack possible

      in Satire  40 upvotes 4 months ago
      A user humorously suggests an extreme hair loss treatment regimen involving multiple medications and therapies, including Dutasteride, Minoxidil, RU58841, and others, claiming it would prevent hair loss but with potential side effects like gynecomastia. The conversation highlights concerns about safety, side effects, and the effectiveness of such a comprehensive approach.

      community Summary of future treatments from 2020

      in Chat  52 upvotes 2 weeks ago
      Hair loss treatments include finasteride, minoxidil, microneedling, dutasteride, CB-03-01, RU-58841, and experimental options like KY-19382 and stem cell therapy. Some treatments are considered ineffective or risky, such as ketoconazole, PRP, and low-level laser therapy.

      community So we’re just ok with taking a research chemical now?

      in Treatment  179 upvotes 4 years ago
      The conversation discusses the use of RU58841, a non-FDA approved research chemical for hair loss, with mixed opinions on its safety and effectiveness. Some users are willing to try it as a last resort after other treatments like Minoxidil and Finasteride failed, while others express concerns about potential long-term side effects and lack of official research.

    Similar Research

    5 / 1000+ results